Opus Genetics Insider Sale: Stable Shares Amid Biotech VolatilityOpus Genetics insider sale: 3,950 shares sold for tax reasons, yet senior exec buying shows confidence—analyzing liquidity and future funding risks.Opus Genetics Inc Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 13/01/2026, 23:37 3 minutes to read